samedan logo
 
 
spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Multimodal 2019

Multimodal 2019

18-20 June 2019
NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 

The exhibition hosts some 300 exhibitors offering the latest logistics and supply chain solutions covering all aspects of logistics from equipment supplier, port, haulier, shipping line, to 3PL and forwarders and will include the latest technological innovations to enter the industry - AI and Blockchain.

The seminar programme will highlight a wide range of industry relevant topics, including Patterns of Global Trade, Disruption technologies, the impact of Brexit, trends and opportunities in modal shift and lots more besides.

On the final day of Multimodal we will be supporting the young talent within the industry by launching a new initiative call Next Gen Logistics Network, which aims to provide support, peer networking and exchange of ideas.

phone +44 (0) 207 384 7759
email jenny.moore@clarionevents.com
web tiny.cc/dr7kyy
email NEC, Birmingham
 
Print this page
Send to a friend
   
spacer
Industry Events

14th Annual Biomarkers Congress

21-22 February 2019, Manchester Central Convention Complex, UK

Oxford Global is proud to present for the 14th year our flagship Biomarkers Congress, taking place 21 – 22 February 2019 in Manchester, UK. An updated programme ensures you will benefit from talks on the latest strategies and technologies impacting growth in the biomarker industry.
More info >>

Banner of DIA_Europe_Events_95 on Samedan Banner of Drug Delivery Partnership 2018_events_97 on Samedan

White Papers

Pharmacovigilance and Risk Management Information in Centralised Applications in the EU

United BioSource Corporation (UBC)

Getting a new medication approved for the EU market through the centralised procedure can be complex and needs expertise. The new EU pharmacovigilance legislation (Good Vigilance Practice, GVP) is now in effect and applicants need to be fully compliant. It is critical to have a thorough understanding of the regulatory process and requirements, and the expectations with regards to the pharmacovigilance system and the risk management plan. Ensuring consistency and an appropriate level of detail in the documentation submitted as part of the approval process will help prevent unnecessary delays.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement